← Back to Westminster Hall Debates
Access to Migraine Treatment
20 March 2024
Lead MP
Dehenna Davison
Responding Minister
Andrew Stephenson
Tags
NHS
Word Count: 13408
Other Contributors: 10
At a Glance
Dehenna Davison raised concerns about access to migraine treatment in Westminster Hall. A government minister responded.
Key Requests to Government:
The lead MP calls for improved medical training for GPs on migraine management, faster access to neurologists and headache specialists, and changes to NICE guidelines to allow earlier use of specialised treatments like CGRP blockers. She also requests the Minister to address funding disparities in accessing these medications across different NHS trusts.
How the Debate Unfolded
MPs spoke in turn to share their views and ask questions. Here's what each person said:
Lead Contributor
Opened the debate
Migraine is a complex neurological condition affecting around 10,000 people per constituency. The debate highlighted significant challenges in diagnosis and treatment access, including long waiting times for specialist care, inconsistent GP training on migraines, and difficulties accessing effective medications such as CGRP blockers due to restrictive NHS guidelines.
Caroline Nokes
Con
Romsey and Southampton North
The MP highlighted the challenges faced by chronic migraine sufferers, who are triggered endlessly by light and noise. She emphasized the need to consider migraine as a disability due to its debilitating impact on employment. The MP also discussed the stigma surrounding migraines, mentioning her personal experience with beta blockers and Botox treatments.
David Duguid
Con
Berwickshire, Roxburgh and Selkirk
The hon. Member shared his personal experience of living with migraines since adolescence and managing symptoms through stress reduction methods.
Gavin Williamson
Con
Stone, Great Wyrley and Penkridge
He highlighted the impact of migraines on individuals and families, noting that one in seven people suffer from migraine with over 1 million experiencing chronic migraine. He shared personal experience of living with someone who suffers from chronic migraine and stressed the debilitating nature of the condition which can severely disrupt daily activities. Williamson cited statistics showing 29% of sufferers had to reduce their working hours due to migraines, while 43% felt they were not believed by their employers when reporting a migraine episode. He called for better understanding in workplaces to support those suffering from migraines and advocated for more investment in treatment and research. Mr Williamson intervened to ask the Minister to consider CGRP blockers further, indicating a potential interest in an announcement about them. He sought reassurance that these treatments would be looked into more closely.
Gregory Campbell
DUP
East Londonderry
Congratulated the hon. Member on securing the debate and suggested there should be discussion with devolved institutions to ensure blockers are more widely available across the UK.
Karin Smyth
Lab
Bristol South
Ms Smyth highlighted that one in seven people in the UK live with migraine, disproportionately affecting women. She noted the debilitating nature of migraines and their impact on employment, noting that 29% of sufferers have moved from full-time to part-time work or left jobs altogether due to the condition. Ms Smyth also expressed concern about long waiting lists for specialist treatment and called for more ambitious measures to tackle economic inactivity caused by migraine.
Greenwich and Woolwich
A constituent reported frustration due to a lack of awareness among medical professionals about specific treatments for hormonal migraines, suggesting that greater knowledge among GPs is essential.
Owen Thompson
SNP
West Aberdeenshire and Kincardine
Commends the hon. Member for Bishop Auckland on raising awareness of migraine and highlights personal experience. Emphasizes the need for better understanding and access to treatment, mentioning long waiting times in Scotland, England, and Wales. Discusses potential alternatives like psilocybin and calls for more research despite challenges due to drug classification. Acknowledges progress but stresses that more needs to be done regarding flexible working rights and GP specialisation.
Paul Girvan
DUP
South Antrim
Noted that many migraine sufferers face difficulties in accessing benefits like personal independence payment due to the unpredictable nature of their condition, impacting their ability to work and live a normal life. Called for more support from the Department of Work and Pensions to help people with chronic migraine access disability benefits.
Philip Hollobone
Con
Kettering
A constituent, Lisa, has written to express her struggles with migraines that leave her exhausted and suffering from facial paralysis and other symptoms. She is glad the debate is taking place.
Wayne David
Lab
Caerphilly
Although not present, the hon. Member sent a testimonial highlighting his ability to minimise migraine severity and frequency over time by managing stress.
Government Response
Andrew Stephenson
Government Response
Acknowledged the importance of the debate on migraine treatment. Mentioned the estimated 10 million people in the UK affected by migraine, highlighted NICE guidelines and the role of primary care and specialist services. Discussed access to treatments like Rimegepant and CGRP blockers, awareness among GPs, and initiatives to reduce waiting times for neurology consultations. Emphasized investment in research through NIHR.
▸
Assessment & feedback
Summary accuracy
About Westminster Hall Debates
Westminster Hall debates are a chance for MPs to raise important issues affecting their constituents and get a response from a government minister. Unlike Prime Minister's Questions, these debates are more in-depth and collaborative. The MP who secured the debate speaks first, other MPs can contribute, and a minister responds with the government's position.